Back

PRIME Education, Inc. (PRIME®)

  • Breast Neoplasms
  • Hyperglycemia

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

PI3K/AKT pathway inhibitors can lead to hyperglycemia, but you can be ready when or if it happens. Tune in to this dynamic webcast designed to elevate your skills to prevent and manage hyperglycemia in patients with metastatic HR+/HER2- breast cancer. Discover real-world strategies, using the latest evidence and guideline-based insights, to optimize the use of PI3K/AKT pathway inhibitors while effectively preventing and managing treatment-related hyperglycemia. Learn how oncology and endocrinology teams can collaborate seamlessly to overcome real-world challenges and improve patient outcomes. Don’t miss this opportunity to gain the insights and tools needed to prevent and manage hyperglycemia, including downloadable point-of-care resources you can implement immediately.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1 creditAAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 1 credit
  • Commercial Support
  • Released
    Mar 31, 2026
  • Last day to claim credit
    Mar 31, 2027 6 months left